ROYCE & ASSOCIATES LP - CHEMOCENTRYX INC ownership

CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 65 filers reported holding CHEMOCENTRYX INC in Q1 2014. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of CHEMOCENTRYX INC
ValueSharesWeighting
Q1 2016$82,000
-69.6%
32,900
-1.2%
0.00%
-50.0%
Q4 2015$270,000
-18.9%
33,300
-39.5%
0.00%0.0%
Q3 2015$333,000
-42.2%
55,000
-21.4%
0.00%0.0%
Q2 2015$576,000
+8.9%
70,0000.0%0.00%0.0%
Q1 2015$529,000
+10.7%
70,0000.0%0.00%0.0%
Q4 2014$478,000
+51.7%
70,0000.0%0.00%
+100.0%
Q3 2014$315,000
-23.2%
70,0000.0%0.00%0.0%
Q2 2014$410,000
-11.6%
70,0000.0%0.00%0.0%
Q1 2014$464,000
-71.6%
70,000
-75.2%
0.00%
-80.0%
Q4 2013$1,633,000282,0000.01%
Other shareholders
CHEMOCENTRYX INC shareholders Q1 2014
NameSharesValueWeighting ↓
Tri Locum Partners LP 276,400$4,726,0001.88%
TANG CAPITAL MANAGEMENT LLC 500,000$8,550,0001.78%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 94,300$7,131,0001.72%
Integral Health Asset Management, LLC 300,000$5,130,0001.48%
SILVERARC CAPITAL MANAGEMENT, LLC 139,200$2,380,0001.35%
MANGROVE PARTNERS IM, LLC 686,300$11,736,0001.05%
Ikarian Capital, LLC 600,000$10,261,0000.72%
Ikarian Capital, LLC 600,000$10,260,0000.72%
Sofinnova Investments, Inc. 517,708$8,853,0000.52%
Birchview Capital, LP 25,000$428,0000.29%
View complete list of CHEMOCENTRYX INC shareholders